EYPT: EyePoint, Inc.
Performance
EYPT -96.77%
Watchlist
Select an item
Summary
EYPT at a glance
EYPT returned -96.77% over the past year and -51.84% a year over five years. Its worst drop in that year was -98.15%, smaller than 0% of stocks on Redstone, and its Sharpe ratio of -1.30 beats 2% of stocks on Redstone. It pays no dividends.
Current Drawdown
-98.08%
Rolling Volatility
295.33%
Actions
Metrics
Risk Indicators
Alpha-182.80%
Beta1.28x
Sharpe-1.30
Sortino-1.42
Omega0.72
Calmar-0.99
Martin-3.68
Profile
About EYPT
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care.
- Sector
- Health Care
- Industry
- Laboratory Analytical Instruments
- Market cap
- $31M
- Listed
- Jan 2005
- Employees
- 214
- Headquarters
- Watertown, MA
- Website
- eyepoint.bio
Comparisons